Radha Rajasingham

About Radha Rajasingham

Radha Rajasingham, With an exceptional h-index of 31 and a recent h-index of 28 (since 2020), a distinguished researcher at University of Minnesota-Twin Cities, specializes in the field of Advanced HIV disease, cryptococcal antigen screening.

His recent articles reflect a diverse array of research interests and contributions to the field:

The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis

Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial

A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19

Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial

Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)

Symptoms of COVID-19 outpatients in the United States

Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness

Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines

Radha Rajasingham Information

University

Position

___

Citations(all)

7971

Citations(since 2020)

6603

Cited By

4576

hIndex(all)

31

hIndex(since 2020)

28

i10Index(all)

59

i10Index(since 2020)

54

Email

University Profile Page

Google Scholar

Radha Rajasingham Skills & Research Interests

Advanced HIV disease

cryptococcal antigen screening

Top articles of Radha Rajasingham

The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis

The Lancet infectious diseases

2022/12/1

Radha Rajasingham
Radha Rajasingham

H-Index: 23

David R Boulware
David R Boulware

H-Index: 47

Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial

2020

A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19

New England journal of medicine

2020/8/6

Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial

Annals of internal medicine

2020/10/20

Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)

2020/4

Symptoms of COVID-19 outpatients in the United States

Open forum infectious diseases

2020/7

Finding the dose for hydroxychloroquine prophylaxis for COVID‐19: the desperate search for effectiveness

Clinical Pharmacology & Therapeutics

2020/10

David R Boulware
David R Boulware

H-Index: 47

Radha Rajasingham
Radha Rajasingham

H-Index: 23

Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines

Clinical infectious diseases

2020/2/14

Radha Rajasingham
Radha Rajasingham

H-Index: 23

Alexander Khoruts
Alexander Khoruts

H-Index: 43

See List of Professors in Radha Rajasingham University(University of Minnesota-Twin Cities)